The post Decoding the Aster-Hyperliquid rivalry – Why THIS is critical for ASTER appeared on BitcoinEthereumNews.com. Aster [ASTER] faced difficulty on the priceThe post Decoding the Aster-Hyperliquid rivalry – Why THIS is critical for ASTER appeared on BitcoinEthereumNews.com. Aster [ASTER] faced difficulty on the price

Decoding the Aster-Hyperliquid rivalry – Why THIS is critical for ASTER

Aster [ASTER] faced difficulty on the price charts. The short-term sell-off can be attributed to the market-wide volatility following Bitcoin’s [BTC] drop below $94.5k support.

The longer-term downtrend of the token was a reflection of market sentiment. In a post on X, Cryptorank showed that Hyperliquid [HYPE] was the more popular decentralized exchange among the two.

Hyperliquid is ranked first by volume and the 24-hour open interest. Aster needs to reclaim market share before its token performance can begin to reflect its position.

Aster threatens to make bearish structure break…once more!

Source: ASTER/USDT on TradingView

The 1-day chart was extremely bearish.

In mid-December, Aster fell below the psychological $1 support level, leaving behind an imbalance (white). This imbalance ranged from $0.83-$0.91. In the first week of January, the Aster token bounced toward this supply zone.

It was unable to test it, instead falling short at $0.813, marking it as the downtrend’s latest lower high. It should be noted that a price bounce beyond $1 was necessary to bring about the beginning of a bullish trend.

The technical indicators on the daily chart reinforced the seller dominance.

Moreover, the A/D indicator began to slide downward in the past two weeks. The Awesome Ostillator had made the faintest of bullish crossovers over the weekend before immediately being forced below the zero line once more.

The DMI, alongside the price making new lows, confirmed that a strong bearish trend was in progress.

What’s next for Aster?

In the coming days, another relief rally is likely. Aster has fallen a long way, and some respite is necessary. Based on the most recent drop, a set of Fibonacci retracement levels was plotted.

It showed that the 78.6% level at $0.695 had confluence with the $0.683-$0.703 supply zone. This region had previously been a demand zone that bulls defended over the past three weeks, but the recent flurry of selling has exhausted the buyers.

Traders’ call to action- Wait for the bounce

The higher timeframe chart confirmed the bearish bias of ASTER, while the lower timeframe price action indicated a potential price bounce. Previously, the bears demonstrated their strength when the supply zone at $0.83 was not even tested.

A similar situation as the failure to reach $0.83, with $0.68-$0.70 not being tested, is possible, especially if Bitcoin fails to bounce back above $94.5k this week.

A move beyond $0.81 and $1 is needed before long-term buyers can enter the market with some degree of certainty.


Final Thoughts

  • Monday’s close below $0.658 would signal ASTER is headed for another downward leg on the price chart.
  • Such a close could see the $0.68-$0.70 area tested as resistance before the $0.55 lows are targeted once more.

Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion.

Next: PENGU falls below $0.011 – Is Manchester City partnership a trap?

Source: https://ambcrypto.com/decoding-the-aster-hyperliquid-rivalry-why-this-is-critical-for-aster/

Market Opportunity
Aster Logo
Aster Price(ASTER)
$0.5805
$0.5805$0.5805
-3.10%
USD
Aster (ASTER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip

The post Gold Hits $3,700 as Sprott’s Wong Says Dollar’s Store-of-Value Crown May Slip appeared on BitcoinEthereumNews.com. Gold is strutting its way into record territory, smashing through $3,700 an ounce Wednesday morning, as Sprott Asset Management strategist Paul Wong says the yellow metal may finally snatch the dollar’s most coveted role: store of value. Wong Warns: Fiscal Dominance Puts U.S. Dollar on Notice, Gold on Top Gold prices eased slightly to $3,678.9 […] Source: https://news.bitcoin.com/gold-hits-3700-as-sprotts-wong-says-dollars-store-of-value-crown-may-slip/
Share
BitcoinEthereumNews2025/09/18 00:33
YouTube Advertising Formats: A Complete Guide for Marketers

YouTube Advertising Formats: A Complete Guide for Marketers

In today’s fast-evolving digital landscape, YouTube has emerged as one of the most powerful platforms for marketers looking to engage audiences through video. With
Share
Techbullion2026/01/21 01:49
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11